HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Saito Selected Research

Chronic Hepatitis C

1/2014Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.
10/2012LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
10/2012Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients.
5/2011The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Saito Research Topics

Disease

68Stomach Neoplasms (Stomach Cancer)
06/2022 - 01/2002
51Neoplasms (Cancer)
05/2022 - 05/2004
13Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 08/2007
13Adenocarcinoma
05/2021 - 10/2011
11Lymphatic Metastasis
05/2022 - 02/2007
10Carcinoma (Carcinomatosis)
10/2020 - 05/2004
9Hemorrhage
05/2022 - 03/2016
9Neoplasm Metastasis (Metastasis)
04/2021 - 08/2007
8Bone Resorption
01/2019 - 06/2004
7Inflammation (Inflammations)
05/2022 - 04/2003
6Hepatocellular Carcinoma (Hepatoma)
12/2021 - 01/2018
6Pancreatic Neoplasms (Pancreatic Cancer)
08/2021 - 11/2016
5Pancreatic Fistula (Pancreatic Fistulas)
05/2020 - 09/2016
4Infections
03/2019 - 04/2006
4Chronic Hepatitis C
01/2014 - 05/2011
3Pathologic Constriction (Stenosis)
04/2022 - 09/2018
3Esophageal Neoplasms (Esophageal Cancer)
04/2022 - 01/2017
3Osteoporosis
12/2021 - 09/2011
3Esophageal Squamous Cell Carcinoma
08/2021 - 06/2002
3Fibrosis (Cirrhosis)
06/2018 - 02/2010
3Melanoma (Melanoma, Malignant)
06/2007 - 03/2005
3Experimental Arthritis
04/2007 - 06/2004
2Colitis
01/2022 - 06/2018
2COVID-19
01/2022 - 12/2020
2Frailty
12/2021 - 11/2020
2Cholangitis
05/2021 - 02/2016
2Breast Neoplasms (Breast Cancer)
01/2020 - 01/2006
2Rib Fractures (Rib Fracture)
01/2020 - 01/2017
2Pancreatitis
12/2019 - 10/2016
2Heart Arrest (Cardiac Arrest)
03/2019 - 01/2017
2Cholangiocarcinoma
09/2018 - 05/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2018 - 12/2016
2Body Weight (Weight, Body)
06/2018 - 08/2011
2Diverticulum
12/2017 - 01/2017
2Necrosis
12/2016 - 10/2006
2Neuroblastoma
01/2016 - 09/2011
2Hyperphosphatemia
11/2011 - 09/2011
2Arthritis (Polyarthritis)
04/2007 - 03/2005

Drug/Important Bio-Agent (IBA)

26Indicators and Reagents (Reagents)IBA
08/2021 - 05/2004
13Pharmaceutical PreparationsIBA
01/2022 - 03/2005
12AntigensIBA
06/2019 - 03/2005
9Tumor Biomarkers (Tumor Markers)IBA
11/2021 - 01/2009
8Peptides (Polypeptides)IBA
05/2009 - 06/2004
7C-Reactive ProteinIBA
06/2022 - 11/2017
7Biomarkers (Surrogate Marker)IBA
06/2019 - 02/2012
6indirubinIBA
01/2020 - 10/2014
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008 - 06/2004
5Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2002
5VaccinesIBA
01/2017 - 01/2005
5Messenger RNA (mRNA)IBA
07/2009 - 03/2005
4AlbuminsIBA
05/2022 - 01/2018
4CarbohydratesIBA
08/2021 - 09/2018
4Carcinoembryonic AntigenIBA
05/2021 - 02/2006
4CytokinesIBA
11/2015 - 03/2005
3Parathyroid Hormone (Parathormone)IBA
12/2021 - 01/2018
3LipidsIBA
01/2020 - 12/2003
3indirubin-3'-monoximeIBA
01/2018 - 01/2017
3Interleukin-10 (Interleukin 10)IBA
01/2009 - 01/2006
3Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2008 - 06/2006
3WP9QY peptideIBA
04/2007 - 03/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2007 - 05/2004
2NivolumabIBA
04/2022 - 12/2019
2Fluorouracil (Carac)FDA LinkGeneric
11/2021 - 01/2007
2Keratin-19 (Keratin 19)IBA
08/2021 - 12/2016
2Antiviral Agents (Antivirals)IBA
01/2021 - 10/2012
2AnticoagulantsIBA
10/2020 - 02/2016
2AmylasesFDA Link
05/2020 - 10/2016
2Adenosine Triphosphate (ATP)IBA
01/2020 - 01/2016
2Semaphorins (Semaphorin)IBA
01/2020 - 01/2019
2EnzymesIBA
05/2019 - 01/2017
2BilirubinIBA
03/2019 - 12/2018
2Serum AlbuminIBA
02/2019 - 03/2018
2Interleukin-6 (Interleukin 6)IBA
06/2018 - 01/2009
2Phosphates (Orthophosphate)IBA
01/2018 - 09/2011
2Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2017 - 01/2016
2Immunoglobulin G (IgG)IBA
01/2017 - 05/2016
2Interleukin-17 (Interleukin 17)IBA
11/2015 - 12/2012
2TegafurIBA
06/2015 - 02/2012
2UracilIBA
06/2015 - 02/2012
2InterferonsIBA
01/2014 - 10/2012
2Ribavirin (Virazole)FDA LinkGeneric
01/2014 - 10/2012
2deoxypyridinolineIBA
05/2009 - 01/2008
2NF-kappa B (NF-kB)IBA
12/2008 - 06/2004
2HLA-A Antigens (HLA-A)IBA
06/2007 - 01/2006

Therapy/Procedure

42Gastrectomy
05/2022 - 01/2002
15Drug Therapy (Chemotherapy)
12/2021 - 03/2005
15Therapeutics
01/2020 - 03/2007
13Lymph Node Excision (Lymph Node Dissection)
04/2022 - 03/2007
8Adjuvant Chemotherapy
04/2022 - 10/2011
5Esophagectomy
04/2022 - 01/2017
4Pancreaticoduodenectomy
03/2019 - 05/2018
3Stents
05/2021 - 06/2015
2Neoadjuvant Therapy
08/2021 - 05/2018
2Pancreatectomy
06/2019 - 03/2019
2Sutures (Suture)
05/2019 - 03/2019
2Hepatectomy
02/2019 - 08/2018
2Lasers (Laser)
08/2018 - 06/2018
2Endoscopic Hemostasis
12/2017 - 10/2017
2Endoscopic Sphincterotomy
10/2016 - 02/2016
2Gastroenterostomy
12/2010 - 03/2010